{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:27:37Z","timestamp":1784338057851,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s13300-022-01354-5","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T14:05:21Z","timestamp":1671631521000},"page":"387-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular Outcomes Observed with Ticagrelor versus Clopidogrel in Type 2 Diabetes Mellitus Patients with Acute Coronary Syndrome: A Meta-analysis"],"prefix":"10.1007","volume":"14","author":[{"given":"Zhiming","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravesh Kumar","family":"Bundhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"issue":"2","key":"1354_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1570161117666190405165151","volume":"18","author":"M Viigimaa","year":"2020","unstructured":"Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular Complications of Type 2 Diabetes Mellitus. Curr Vasc Pharmacol. 2020;18(2):110\u20136.","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"1354_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1570161117666190328095249","volume":"18","author":"N Katsiki","year":"2020","unstructured":"Katsiki N, Papanas N. Diabetes Mellitus and Acute Coronary Syndrome: A Lethal Combination Requiring Better Therapeutic Strategies. Curr Vasc Pharmacol. 2020;18(1):77\u20139.","journal-title":"Curr Vasc Pharmacol"},{"key":"1354_CR3","doi-asserted-by":"crossref","unstructured":"Levine GN,\u00a0Bates ER,\u00a0Bittl JA, et\u00a0al. 2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation.\u00a02016;134(10):e123\u201355.","DOI":"10.1161\/CIR.0000000000000452"},{"key":"1354_CR4","doi-asserted-by":"crossref","unstructured":"Dharam JK,\u00a0Steven PM,\u00a0Carlos AA,\u00a0Darren KM. State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus. Curr Cardiovasc Risk Rep.\u00a02015;9:4.","DOI":"10.1007\/s12170-014-0430-5"},{"key":"1354_CR5","doi-asserted-by":"crossref","unstructured":"Arun N,\u00a0Azfar GZ,\u00a0Sally MM. Platelet Hyperactivity in Type 2 Diabetes: Role of Antiplatelet Agents. Diab Vasc Dis Res.\u00a02008;5(2):138\u201344.","DOI":"10.3132\/dvdr.2008.023"},{"key":"1354_CR6","doi-asserted-by":"crossref","unstructured":"Chadi D,\u00a0Elias BH,\u00a0Mazen SA-F. A New Era for Antiplatelet Therapy in Patients with Acute Coronary Syndrome. Am J Med Sci.\u00a02010;340(5):407\u201311.","DOI":"10.1097\/MAJ.0b013e3181ee5bfb"},{"issue":"16","key":"1354_CR7","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","volume":"381","author":"S Sch\u00fcpke","year":"2019","unstructured":"Sch\u00fcpke S, Neumann F-J, Menichelli M, et\u00a0al. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. N Engl J Med. 2019;381(16):1524\u201334.","journal-title":"N Engl J Med"},{"issue":"19","key":"1354_CR8","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.jcin.2020.07.032","volume":"13","author":"G Ndrepepa","year":"2020","unstructured":"Ndrepepa G, Kastrati A, Menichelli M, et\u00a0al. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus. JACC Cardiovasc Interv. 2020;13(19):2238\u201347.","journal-title":"JACC Cardiovasc Interv"},{"key":"1354_CR9","doi-asserted-by":"crossref","unstructured":"Quinlan DJ, Eikelboom JW, Goodman SG, Welsh RC, Fitchett DH, Th\u00e9roux P, Mehta SR. Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes. Eur Heart J. 2011;32(18):2256\u201365.","DOI":"10.1093\/eurheartj\/ehr143"},{"key":"1354_CR10","doi-asserted-by":"crossref","unstructured":"Wouter JK,\u00a0Nan van G,\u00a0Mariet van der HL, et\u00a0al. The Prognostic Value of Bleeding Academic Research Consortium (BARC)-Defined Bleeding Complications in ST-Segment Elevation Myocardial Infarction: A Comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications. J Am Coll Cardiol.\u00a02014;63(18):1866\u201375.","DOI":"10.1016\/j.jacc.2014.01.069"},{"key":"1354_CR11","doi-asserted-by":"crossref","unstructured":"Julian PTH,\u00a0Douglas GA,\u00a0Peter CG et\u00a0al. The Cochrane Collaboration's Tool for Assessing Risk of Bias in Randomised Trials. BMJ.\u00a02011;343:d5928.","DOI":"10.1136\/bmj.d5928"},{"issue":"9","key":"1354_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical Evaluation of the Newcastle-Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta-Analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"372","key":"1354_CR13","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, The PRISMA Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ. 2020;2021(372): n71.","journal-title":"BMJ"},{"key":"1354_CR14","doi-asserted-by":"crossref","unstructured":"Kye TA,\u00a0Seok-Woo S,\u00a0Ung LC et\u00a0al. Comparison of 1-Year Clinical Outcomes between Prasugrel and Ticagrelor versus Clopidogrel in Type 2 Diabetes Patients with Acute Myocardial Infarction underwent Successful Percutaneous Coronary Intervention. Medicine (Baltimore).\u00a02019;98(11):e14833.","DOI":"10.1097\/MD.0000000000014833"},{"key":"1354_CR15","doi-asserted-by":"publisher","first-page":"5546260","DOI":"10.1155\/2021\/5546260","volume":"2021","author":"P He","year":"2021","unstructured":"He P, Luo X, Li J, et\u00a0al. Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes. Cardiovasc Ther. 2021;2021:5546260.","journal-title":"Cardiovasc Ther"},{"key":"1354_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1515\/med-2019-0017","volume":"14","author":"D-T Li","year":"2019","unstructured":"Li D-T, Li S-B, Zheng J-Y, et\u00a0al. Analysis of Ticagrelor\u2019s Cardio-protective Effects on Patients with ST-Segment Elevation Acute Coronary Syndrome Accompanied with Diabetes. Open Med (Wars). 2019;14:234\u201340.","journal-title":"Open Med (Wars)"},{"issue":"3 Suppl","key":"1354_CR17","first-page":"312","volume":"23","author":"Y Liu","year":"2019","unstructured":"Liu Y, Ding L-Y, Li X-Z. Therapy with Ticagrelor for ST-Elevated Acute Coronary Syndrome Accompanied by Diabetes Mellitus. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):312\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"1354_CR18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1055\/s-0040-1713375","volume":"120","author":"Z Liu","year":"2020","unstructured":"Liu Z, Tian R, Wang Y, et\u00a0al. Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes. Thromb Haemost. 2020;120(8):1221\u20139.","journal-title":"Thromb Haemost"},{"key":"1354_CR19","doi-asserted-by":"crossref","unstructured":"Mina WM,\u00a0Mohamed AE,\u00a0Hala FZ,\u00a0Hanan SE-A. Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared with Ticagrelor in Percutaneous Coronary Intervention-Treated Acute Coronary Syndrome Patients. J Cardiovasc Pharmacol.\u00a02020;76(4):478\u2013488.","DOI":"10.1097\/FJC.0000000000000881"},{"issue":"19","key":"1354_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019969","volume":"99","author":"C-A Wang","year":"2020","unstructured":"Wang C-A, Hsieh Y-C, Huang C-Y, et\u00a0al. Comparison between Ticagrelor versus Clopidogrel in Long Term Outcomes of Taiwanese Diabetic Subjects with Acute Coronary Syndrome Undergoing Successful Revascularization: From TSOC ACS-DM Registry. Medicine (Baltimore). 2020;99(19): e19969.","journal-title":"Medicine (Baltimore)"},{"key":"1354_CR21","doi-asserted-by":"crossref","unstructured":"Stefan J,\u00a0Dominick JA,\u00a0Jan HC\u00a0et\u00a0al. Ticagrelor vs. Clopidogrel in Patients with Acute Coronary Syndromes and Diabetes: A Substudy from the PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Eur Heart J.\u00a02010;31(24):3006\u201316.","DOI":"10.1093\/eurheartj\/ehq325"},{"key":"1354_CR22","doi-asserted-by":"crossref","unstructured":"Joseph MS,\u00a0Dominick JA,\u00a0Francesco F et\u00a0al. Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention. J Am Heart Assoc.\u00a02017;6(4):e005650.","DOI":"10.1161\/JAHA.117.005650"},{"issue":"15","key":"1354_CR23","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCULATIONAHA.120.048770","volume":"142","author":"F Franchi","year":"2020","unstructured":"Franchi F, Rollini F, Been L, et\u00a0al. Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study. Circulation. 2020;142(15):1500\u20132.","journal-title":"Circulation"},{"issue":"11","key":"1354_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.116.023743","volume":"134","author":"F Mangiacapra","year":"2016","unstructured":"Mangiacapra F, Panaioli E, Colaiori I, et\u00a0al. Clopidogrel versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated with Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients). Circulation. 2016;134(11):835\u20137.","journal-title":"Circulation"},{"issue":"10","key":"1354_CR25","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1160\/TH17-04-0277","volume":"117","author":"MU Zafar","year":"2017","unstructured":"Zafar MU, Baber U, Smith DA, et\u00a0al. Antithrombotic Potency of Ticagrelor versus Clopidogrel in Type-2 Diabetic Patients with Cardiovascular Disease. Thromb Haemost. 2017;117(10):1981\u20138.","journal-title":"Thromb Haemost"},{"issue":"24","key":"1354_CR26","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","volume":"62","author":"US Tantry","year":"2013","unstructured":"Tantry US, Bonello L, Aradi D, et\u00a0al. Consensus and Update on the Definition of on-Treatment Platelet Reactivity to Adenosine Diphosphate Associated with Ischemia and Bleeding. J Am Coll Cardiol. 2013;62(24):2261\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"1354_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1908077","volume":"381","author":"PG Steg","year":"2019","unstructured":"Steg PG, Bhatt DL, Simon T, et\u00a0al. Ticagrelor in Patients with Stable Coronary Disease and Diabetes. N Engl J Med. 2019;381(14):1309\u201320.","journal-title":"N Engl J Med"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-022-01354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-022-01354-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-022-01354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T20:52:10Z","timestamp":1677012730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-022-01354-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s13300-022-01354-5","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"19 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}